The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease

Abstract Background There is growing interest in identifying sensitive composite cognitive tests to serve as primary endpoints in preclinical Alzheimer’s disease (AD) treatment trials. We reported previously a composite cognitive test score sensitive to tracking preclinical AD decline up to 5 years...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jessica B. Langbaum, Noel N. Ellison, Angelika Caputo, Ronald G. Thomas, Carolyn Langlois, Marie-Emmanuelle Riviere, Ana Graf, Cristina Lopez Lopez, Eric M. Reiman, Pierre N. Tariot, Suzanne B. Hendrix
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2020-05-01
Edice:	Alzheimer’s Research & Therapy
Témata:	Preclinical Alzheimer’s disease Cognition Composite cognitive endpoint Clinical trials
On-line přístup:	http://link.springer.com/article/10.1186/s13195-020-00633-2
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!